180 related articles for article (PubMed ID: 32984404)
1. Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
Garcia KS; Moutinho BD; de Azevedo MFC; Queiroz NSF; Milani LR; Sanches LN; Barros LL; Oba J; Carlos AS; Damião AOMC; Sipahi AM
Inflamm Intest Dis; 2020 Jun; 5(2):93-97. PubMed ID: 32984404
[TBL] [Abstract][Full Text] [Related]
2. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
[TBL] [Abstract][Full Text] [Related]
4. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Disease Patients' Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey.
Revés JB; Frias-Gomes C; Morão B; Nascimento C; Palmela C; Fidalgo C; Roque Ramos L; Sampaio A; Glória L; Cravo M; Torres J
GE Port J Gastroenterol; 2021 Sep; 5(5):1-9. PubMed ID: 34934777
[TBL] [Abstract][Full Text] [Related]
6. Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
Rosen MH; Axelrad J; Hudesman D; Rubin DT; Chang S
Inflamm Bowel Dis; 2020 Jun; 26(7):971-973. PubMed ID: 32393973
[TBL] [Abstract][Full Text] [Related]
7. Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19.
Mounsif S; Setouani H; Nadi A; Ghalim F; Delsa H
Cureus; 2022 Dec; 14(12):e32153. PubMed ID: 36601162
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
[TBL] [Abstract][Full Text] [Related]
9. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
Din S; Kent A; Pollok RC; Meade S; Kennedy NA; Arnott I; Beattie RM; Chua F; Cooney R; Dart RJ; Galloway J; Gaya DR; Ghosh S; Griffiths M; Hancock L; Hansen R; Hart A; Lamb CA; Lees CW; Limdi JK; Lindsay JO; Patel K; Powell N; Murray CD; Probert C; Raine T; Selinger C; Sebastian S; Smith PJ; Tozer P; Ustianowski A; Younge L; Samaan MA; Irving PM
Gut; 2020 Oct; 69(10):1769-1777. PubMed ID: 32513653
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
Bourgonje AR; van Linschoten RCA; West RL; van Dijk MA; van Leer-Buter CC; Kats-Ugurlu G; Pierik MJ; Festen EAM; Weersma RK; Dijkstra G
Therap Adv Gastroenterol; 2021; 14():17562848211012595. PubMed ID: 33995584
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
12. [The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel disease].
Tóbi L; Prehoda B; Balogh A; Dezsőfi-Gottl A; Cseh Á
Orv Hetil; 2022 Feb; 163(6):214-221. PubMed ID: 35124570
[TBL] [Abstract][Full Text] [Related]
13. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
Moum KM; Moum B; Opheim R
Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
[TBL] [Abstract][Full Text] [Related]
14. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI
J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
16. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
Tepasse PR; Vollenberg R; Nowacki TM
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
[TBL] [Abstract][Full Text] [Related]
18. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
[TBL] [Abstract][Full Text] [Related]
19. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.
Kamath C; Brenner EJ
Curr Res Pharmacol Drug Discov; 2022; 3():100101. PubMed ID: 35496814
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey.
Spagnuolo R; Larussa T; Iannelli C; Cosco C; Nisticò E; Manduci E; Bruno A; Boccuto L; Abenavoli L; Luzza F; Doldo P
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
